Filing Details
- Accession Number:
- 0001144204-16-123136
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2016-09-07 18:58:36
- Reporting Period:
- 2016-09-02
- Filing Date:
- 2016-09-07
- Accepted Time:
- 2016-09-07 18:58:36
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1012477 | Flamel Technologies Sa | FLML | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1144178 | S Michael Anderson | 33, Avenue Du Docteur Georges Levy Venissieux I0 69200 | Chief Executive Officer | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Adss | Acquisiton | 2016-09-02 | 2,000 | $14.12 | 191,250 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Reported Derivative Holdings
| Sec. Name | Sec. Type | Price | Date | Expiration Date | Amount | Remaning Holdings | Nature of Ownership |
|---|---|---|---|---|---|---|---|
| Adss | Stock Option (right to buy) | $6.93 | 2022-03-08 | 275,000 | 275,000 | Direct | |
| Adss | Stock Option (right to buy) | $4.07 | 2023-02-01 | 80,500 | 80,500 | Direct | |
| Adss | Stock Option (right to buy) | $16.30 | 2024-12-11 | 200,000 | 200,000 | Direct | |
| Adss | Stock Option (right to buy) | $14.35 | 2025-12-10 | 200,000 | 200,000 | Direct |
| Expiration Date | Amount | Remaning Holdings | Nature of Ownership |
|---|---|---|---|
| 2022-03-08 | 275,000 | 275,000 | Direct |
| 2023-02-01 | 80,500 | 80,500 | Direct |
| 2024-12-11 | 200,000 | 200,000 | Direct |
| 2025-12-10 | 200,000 | 200,000 | Direct |
Footnotes
- The issuer's "ADSs" are American Depositary Shares, with each ADS representing one ordinary share, nominal value 0.122 Euros per share, of the issuer; ADSs are represented by American Depositary Receipts.
- Includes (a) 50,000 restricted ADSs granted under the issuer's "Free Share" award program on 12/11/2014, all of which will be issued to the reporting person on the fourth anniversary of the grant date, provided that the reporting person continues to be employed by the issuer or an affiliate thereof on the second anniversary of the grant date; and (b) 50,000 restricted ADSs granted under the issuer's "Free Share" award program on 8/10/2016, all of which will be issued to the reporting person on the second anniversary of the grant date.
- Options became exercisable in four equal amounts over the first four anniversaries after the 03/08/2012 grant date.
- Options become exercisable as to 20,125 ADSs on each of the first four anniversaries after the 02/01/2013 grant date.
- Options become exercisable as to 50,000 ADSs on each of the first four anniversaries after the 12/11/2014 grant date.
- Options become exercisable as to 50,000 ADSs on each of the first four anniversaries after the 12/10/2015 grant date.
Billionaire Hedge Funds
